Evaluación clínica y económica de la profilaxis con fondaparinux en comparación con enoxaparina en cirugía ortopédica mayor
- 1 April 2006
- journal article
- Published by Springer Nature in PharmacoEconomics Spanish Research Articles
- Vol. 3 (2) , 75-88
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparisonThe Lancet, 2002
- Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Hip-Fracture SurgeryNew England Journal of Medicine, 2001
- Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Elective Major Knee SurgeryNew England Journal of Medicine, 2001
- Prevention of Venous ThromboembolismChest, 2001
- A pharmacoeconomic assessment of enoxaparin and warfarin as prophylaxis for deep vein thrombosis in patients undergoing knee replacement surgeryClinical Therapeutics, 1998
- Economics of Thromboprophylaxis in Total Hip Replacement SurgeryPharmacoEconomics, 1997
- Pharmacoeconomic model of enoxaparin versus heparin for prevention of deep vein thrombosis after total hip replacementAmerican Journal of Health-System Pharmacy, 1997
- Comparison of the cost of preventing postoperative deep vein thrombosis with either unfractionated or low molecular weight heparinBritish Journal of Surgery, 1996
- Economic evaluation of standard heparin and enoxaparin for prophylaxis against deep vein thrombosis in elective hip surgeryBritish Journal of Surgery, 1994
- Prevention of Deep-Vein Thrombosis following Total Hip Replacement Surgery with Enoxaparin versus Unfractionated Heparin: A Pharmacoeconomic EvaluationAnnals of Pharmacotherapy, 1994